Biotech Bulls Roar as AI Hype Faces Backlash

Don’t Stop Here

More To Explore

RVMD: Key Data on Daraxonrasib at AACR 2026!

Introduction Revolution Medicines, Inc. (NASDAQ: RVMD) is a late-stage oncology biotech focused on targeting RAS-driven cancers (marketchameleon.com) (www.biospace.com). The company’s lead drug daraxonrasib (also known

Markets Rebound Amid AI Boom and Water Crisis

Opening Recap Market Pulse: Equities bounced back into record territory as major indexes reclaimed pre-Iran conflict levels. Key Movers: AMC Robotics stunned Wall Street with